Objective: This article is a critical review of the literature concerning thyroid cartilage chondrosarcoma and is particularly focused on the management and prognosis of this rare entity. Study Design: A review of all the cases of thyroid cartilage chondrosarcoma reported in the literature up to January 2013. Methods: The search was carried out through the introduction of the MeSH terms: Chondrosarcoma, Laryngeal Cartilages, Thyroid Cartilage, Therapeutics. All the studies related to thyroid cartilage chondrosarcoma were selected together with a newly presented case. Results: A total of 47 cases have been described in the literature, and 35 of these include sufficient data for statistical analysis. The age of patients ranged from 40 to 77 years, with a male predilection (88.6%). The main symptoms were neck mass and hoarseness. Grade I and II tumors were most frequent. A total of 13 cases described an extension of the tumor beyond the thyroid cartilage. The most common treatment was partial laryngectomy (50%). All patients who died were male, with grade II or II-III tumor or associated sarcoma, had metastases and received radiotherapy in addition to total laryngectomy. Conclusion: Patient age and tumor size does not influence the prognosis. Tumor grade I and I-II have good prognoses, whereas the prognosis is unpredictable in tumors between grade II and III. Patients with associated sarcoma, or metastasis, have a worse prognosis. Partial laryngectomy is a good therapeutic option, although total laryngectomy is sometimes required in order to ensure complete resection.
lages", "Thyroid Cartilage", "Therapeutics".
First, a search was performed in clinical practice guideline databases (National Guideline Clearinghouse, Guidelines Finder NHS, CMA Infobase), however no references were found. Therefore a search of systematic reviews (Clinical Evidence, The Cochrane Library, DARE) was carried out, again without results. Finally, a review of original articles in PubMed was undertaken together with articles identified during this search process in order to add additional references.
Selection Criteria
Once all the abstracts were obtained, the studies related to thyroid cartilage chondrosarcoma were selected. Articles not directly related to laryngeal chondrosarcoma were discarded.
Case Report
A 63-year-old man came to the emergency department complaining of an anterior cervical mass of 3 months evolution. The patient reported discomfort on swallowing and the sensation of a foreign body in the pharynx. The oropharyngeal examination and the fibroscopy were normal. The physical examination revealed a painless, hard, rounded cervical lesion, measuring 1.5 cm in diameter, which moved on swallowing and was adhered to the deep planes, in the left cervical ganglion level III.
The CT scan showed an expansive mass of 2.3 cm in the posterior area of the left thyroid cartilage lamina with inflation and cortical breakage (Figure 1 ). Calcific foci with a popcorn-like appearance suggested a chondral origin. The MR showed a lesion indicating a low degree chondroma or chondrosarcoma of the left thyroid cartilage lamina (Figure 2) . The patient underwent partial left laryngectomy. Histological examination of the surgical specimen confirmed the diagnosis of grade II chondrosarcoma with cellular pleomorphism and atypia, with a maximum diameter of 1.8 cm, located on ossified thyroid cartilage. The lesion infiltrated the bone surface and prelaryngeal muscles. Areas of necrosis were identified within the tumor. Surgical margins showed no tumor infiltration (Figure 3) .
Follow-up evaluations up to the present (51 months) have revealed no clinical signs of recurrent tumor or metastases.
Statistical Analysis
Data were analyzed using Statistical Package for Social Science (SPSS) version 15.0. Statistics procedures were established according to the recommendations of a professional statistician. The ANOVA test, three-way ANOVA, and the Turkey test for multiple comparisons were used for statistical analyses of the measured data. Descriptive statistics mean, median, and standard deviation (SD) were calculated in each group. The comparison between variables was evaluated by the χ 2 test. All p values were two-sided and values of 0.05 or less were considered to indicate statistical significance.
Results
A total of 47 cases reporting thyroid chondrosarcoma were found in the literature, including the present case. Only 35 cases provided sufficient data for statistical analysis ( Table 1 ). Patient ages ranged from 40 to 77 years, (mean age 62 years) with a standard deviation (SD) of 11.2 years. The disease was more frequent in males (n: 31, 88.6%). The main symptoms were neck mass and hoarseness. The main location of the thyroid cartilage chondrosarcoma was the right thyroid lamina, although the exact location was not specified in many reports. In 57.2% of patients, the tumor size was evaluated by pathology and CT, with a range of 8.6 -40 mm. In 34.3% of cases, the tumor size was not stated. Tumors were mainly grade I and II ( Table 1) .
A total of 13 cases described tumor extension beyond the thyroid cartilage, with the cricoid cartilage and prelaryngeal muscles being the most common sitses. Among these 13 patients, 2 died from the disease (DOD) (1 with sarcoma), 5 with no evidence of disease (NED), and 6 patients had no reported follow-up (2 with sarcoma). All the patients with sarcoma showed strap muscle involvement ( Table 1) .
The main treatment used was partial laryngectomy in 50% of the patients (n = 17), and total laryngectomy in 26% (n = 9). The treatment received was not specified in 1 patient ( Table 2) . Follow-up was documented in 74.3% of patients, with 84.6% being free of disease but 15.4% died ( Table 1) . Metastases were reported in 4 cases, 3 in the lung and 1 case in the tonsil.
When comparing the NED and DOD patients, it was observed that the mean age of those who died was 66.5 ± 7.5, and those free of disease was 58.8 ± 11.7, however this difference was not statistically significant. All patients who died were male and had grade II and II-III tumors or associated sarcoma. In the NED group there were 16 males and 4 females, 16 patients had grade I, I-II tumors, 3 patients grade II and 1 patient grade III. There was no follow-up specified in 7 patients with tumors between grade I and II, and in 2 patients with associated sarcoma ( Table 3) .
Patients who died presented larger tumors than those who were disease free (57.5 ± 17.6 vs 39.8 ± 18.5), however these data are not statistically significant. No statistically significant association was found between clinical status, clinical presentation or tumor location. No statistically significant association was found between tumor size and histological grade. All those that died had metastases and received total laryngectomy (TL) and radiation therapy (RT). None of the NED patient had metastases, 13 patients were treated by partial laryngectomy (PL), and 8 patients by TL. One case required TL after PL.
Discussion
In thyroid chondrosarcoma there is a male predilection (9:1) similar to laryngeal chondrosarcoma (5-10:1) [22] with the same age range (4 th -7 th decades) [23] . The main symptoms were neck mass and hoarseness similar to laryngeal chondrosarcoma.
Surgical treatment is known to be the most effective treatment modality. In low grade chondrosarcomas, conservation surgery ensuring complete tumor resection, which includes a margin of normal cartilage, is recommended [6] [34] . Total laryngectomy is reserved for large primary tumors or recurrence when complete resection by partial laryngectomy is not feasible [19] [25] [34]- [36] . There is no added survival benefit with total instead of partial laryngectomy. The main treatment in thyroid chondrosarcoma was PL, with a good prognosis in all except 4 patients, who in 2 cases required subsequent TL due to recurrence, however this was not specified in the other cases. The majority of patients who underwent TL had laryngeal, especially cricoid, cartilage extension. Considering the rare involvement of cervical lymph nodes, radical neck dissection is not routinely performed and must be reserved for cases in which the clinical picture suggests lymph node metastases. Tumor-free margins did not represent a guarantee that recurrence would not take place. These data should always be taken into consideration by the surgeon when conducting long-term follow-up [15] .
Radiotherapy should be used for palliative purpose in unresectable cases, or as an adjuvant therapy in cases of residual disease [37] . In our review, 5 patients had RT as adjuvant therapy, 4 of them had metastases and died, and 1 patient had associated sarcoma without follow-up. Chemotherapy can be applied as an adjuvant therapy in high grade mesenchymal chondrosarcomas [4] . In our review, no patients received chemotherapy.
The prognostic factors are tumor grade and primary site, with resectability being the most important prognostic factor for some authors [24] . In our review we found that the most important prognostic factor was tumor grade. All patients with grade I and I-II survived, and all who died were grade II and II-III, or had sarcoma associated. The dedifferentiated variant is known for its poor prognosis. No statistically significant association was seen between tumor size and histological grade as previously proposed. Although there are differences between NED and DOD patients with respect to age and tumor size, these differences are not statistically significant. Although it has been proposed that the most common cause of death is local recurrence, and not metastasis [24] , this review found that all patients with metastases died, with the metastases or its complications being the cause of death, and 2 patients with local recurrence survived.
Conclusions
 The main location of thyroid cartilage chondrosarcoma is the right ala of the thyroid. The principal symptom is neck mass. The average age at diagnosis is 62 years of age (40 -77 years), and it is more common in men than women (9:1).  Patients' clinical symptoms at the time of diagnosis do not correlate with tumor extension or prognosis.  Patient age and tumor size does not influence the prognosis, although patients with a worse prognosis were older and had larger tumors.  Patients with grade I and I-II tumors have good prognosis. Patients with tumors between grade II and III have unpredictable prognoses. Patients with associated sarcoma have a worse prognosis.  Care must be taken with patients with strap muscle involvement because they may have an associated sarcoma.  Patients with metastases have a poor prognosis.  Partial laryngectomy is a good therapeutic option, although sometimes a total laryngectomy is required to ensure complete resection. There is no added survival benefit with total instead of partial laryngectomy.  Radiotherapy has not demonstrated improved survival.
